Venture Capital

Updated:

Evolution Venture Partners

Philip Taub and John Andreadis run EVP, a healthcare investment banking boutique that raises capital for life sciences companies from New York.

Evolution Venture Partners logo

Evolution Venture Partners

Evolution Venture Partners is a private equity firm based in New York, US. It focuses on venture capital investments. The firm has a team of four staff, including four investment professionals.

General information

Firm type

Venture Capital

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, United States

Principals

Philip Taub

Managing Partner

John Andreadis

Managing Partner

Sector focus

Life SciencesBiotechnologyHealthcare Services

Frequently asked questions

Who runs investment decisions at Evolution Venture Partners?

Managing partners Philip Taub and John Andreadis lead the firm. They are registered with American Global Wealth Management and personally handle financings and securities transactions. EVP does not deploy a proprietary fund, so the managing partners drive client selection and transaction structuring rather than internal portfolio allocation.

Is Evolution Venture Partners structured as a single family office?

No. Evolution Venture Partners is an asset manager — specifically a healthcare investment banking boutique. It earns fees by advising public and private healthcare companies on capital raises, mergers and acquisitions, and strategic partnering, rather than managing a family's private wealth or balance sheet.

Does Evolution Venture Partners participate in fund commitments or only direct deals?

EVP acts solely as an advisor. The firm does not commit capital from a proprietary fund. It raises capital from institutional investors — including venture capital and private equity funds, corporate strategics, and family offices — for its clients' financings and strategic transactions.

What investment stages does Evolution Venture Partners typically target?

EVP works across the corporate lifecycle. Its practice spans traditional venture financings for private life sciences companies, PIPE and follow-on transactions for public companies, and M&A advisory. The firm frequently manages parallel processes that combine equity capital raises with non-dilutive licensing or partnering deals.

Which sectors does Evolution Venture Partners focus on?

The firm concentrates on life sciences, biotechnology, and health and wellness. Within those verticals, EVP engages with companies developing breakthrough technologies to improve health, prevent illness, and support healthy lifestyles. There is no public indication of activity in other healthcare sub-sectors such as healthcare IT or payer services.

How does Evolution Venture Partners source its deal flow?

EVP relies on the networks of its managing partners and its advisory board of clinicians and pharmaceutical executives to access private and public healthcare companies seeking capital. The firm's registered broker-dealer status through American Global Wealth Management also positions it to underwrite and place securities, which generates inbound mandates from issuers directly.

Does Evolution Venture Partners maintain philanthropic structures?

There is no public disclosure of a philanthropic foundation, donor-advised fund, or impact investing vehicle tied to Evolution Venture Partners or its managing partners. The firm's website focuses exclusively on its investment banking services.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Venture Capital profiles